Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

Júlia Corominas, Carme Garriga, Antoni Prenafeta, Alexandra Moros, Manuel Cañete, Antonio Barreiro, Luis González-González, Laia Madrenas, Irina Güell, Bonaventura Clotet, Nuria Izquierdo-Useros, Dàlia Raïch-Regué, Marçal Gallemí, Julià Blanco, Edwards Pradenas, Benjamin Trinité, Julia G Prado, Oscar Blanch-Lombarte, Raúl Pérez-Caballero, Montserrat Plana, Ignasi Esteban, Carmen Pastor-Quiñones, Xavier Núñez-Costa, Rachel Abu Taleb, Paula McSkimming, Alex Soriano, Jocelyn Nava, Jesse Omar Anagua, Rafel Ramos, Ruth Martí Lluch, Aida Corpes Comes, Susana Otero Romero, Xavier Martinez Gomez, Carla Sans-Pola, José Moltó, Susana Benet, Lucía Bailón, Jose R Arribas, Alberto M Borobia, Javier Queiruga Parada, Jorge Navarro-Pérez, Maria José Forner Giner, Rafael Ortí Lucas, María del Mar Vázquez Jiménez, Salvador Oña Compán, Melchor Alvarez-Mon, Daniel Troncoso, Eunate Arana-Arri, Susana Meijide, Natale Imaz-Ayo, Patricia Muñoz García, Sofía de la Villa Martínez, Sara Rodríguez Fernández, Teresa Prat, Èlia Torroella, Laura Ferrer
doi: https://doi.org/10.1101/2022.07.05.22277210

Article Information

doi 
https://doi.org/10.1101/2022.07.05.22277210
History 
  • March 2, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Júlia Corominasa,†,
  2. Carme Garrigaa,†,
  3. Antoni Prenafetaa,
  4. Alexandra Morosa,
  5. Manuel Cañetea,
  6. Antonio Barreiroa,
  7. Luis González-Gonzáleza,
  8. Laia Madrenasa,
  9. Irina Güella,
  10. Bonaventura Clotetb,
  11. Nuria Izquierdo-Userosb,o,
  12. Dàlia Raïch-Reguéb,
  13. Marçal Gallemíb,
  14. Julià Blancob,o,r,s,
  15. Edwards Pradenasb,
  16. Benjamin Trinitéb,o,
  17. Julia G Pradob,o,s,
  18. Oscar Blanch-Lombarteb,
  19. Raúl Pérez-Caballerob,
  20. Montserrat Planac,o,
  21. Ignasi Estebanc,
  22. Carmen Pastor-Quiñonesc,
  23. Xavier Núñez-Costad,
  24. Rachel Abu Talebd,
  25. Paula McSkimmingd,
  26. Alex Sorianoe,o,
  27. Jocelyn Navae,
  28. Jesse Omar Anaguae,
  29. Rafel Ramosf,p,
  30. Ruth Martí Lluchf,p,
  31. Aida Corpes Comesf,
  32. Susana Otero Romerog,q,v,
  33. Xavier Martinez Gomezg,q,
  34. Carla Sans-Polag,w,x,
  35. José Moltóh,o,
  36. Susana Beneth,
  37. Lucía Bailónh,
  38. Jose R Arribasi,o,
  39. Alberto M Borobiai,o,t,
  40. Javier Queiruga Paradai,t,
  41. Jorge Navarro-Pérezj,
  42. Maria José Forner Ginerj,
  43. Rafael Ortí Lucasj,
  44. María del Mar Vázquez Jiménezk,
  45. Salvador Oña Compánk,
  46. Melchor Alvarez-Monl,
  47. Daniel Troncosol,
  48. Eunate Arana-Arrim,
  49. Susana Meijidem,
  50. Natale Imaz-Ayom,
  51. Patricia Muñoz Garcían,u,
  52. Sofía de la Villa Martínezn,
  53. Sara Rodríguez Fernándezn,
  54. Teresa Prata,*,
  55. Èlia Torroellaa and
  56. Laura Ferrera
  1. aHIPRA, Avinguda de la Selva, 135, 17170 Amer, Girona, Spain
  2. bIrsiCaixa AIDS Research Institute, Carretera de Canyet, s/n, Can Ruti Campus, 08916, Badalona, Spain
  3. cAIDS Research Group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), C/ del Rosselló, 149, 08036 Barcelona, Spain
  4. dVeristat, LLC, Barcelona, Spain, Toronto, Canada, Pickmere, UK
  5. eHospital Clínic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), C. de Villarroel, 170, 08036 Barcelona, Spain
  6. fInstitut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Biomedical Research Institute, Girona (IdIBGi), Catalan Institute of Health, Carrer del Dr. Castany, s/n, 17190 Salt, Girona, Spain
  7. gHospital Universitari Vall d’Hebron, Pg. de la Vall d’Hebron, 119, 08035, Barcelona, Spain
  8. hInfectious Diseases Department. Hospital Universitari Germans Trias i Pujol, Carretera de Canyet, s/n, Badalona, Spain
  9. iInfectious Diseases Unit. Internal Medicine Department. La Paz University Hospital, IdiPAZ, C. de Pedro Rico, 6, 28029 Madrid, Spain
  10. jHospital Clínico Universitario Valencia, Av. de Blasco Ibáñez, 17, 46010 València, Spain
  11. kHospital Regional Universitario de Málaga, Av. de Carlos Haya, 84, 29010, Málaga, Spain
  12. lHospital Universitario Príncipe de Asturias, Av. Principal de la Universidad, s/n, 28805 Alcalá de Henares, Madrid, Spain
  13. mScientific Coordination, Biocruces Bizkaia HRI, Osakidetza, Cruces Plaza, 48903 Barakaldo, Bizkaia, Spain
  14. nInstituto de Investigación Sanitaria Hospital Gregorio Marañón, C. del Dr. Esquerdo, 46, 28007 Madrid, Spain
  15. oCIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain
  16. pDepartment of Medical Sciences, School of Medicine, University of Girona, Plaça de Sant Domènec, 3, 17004 Girona, Spain
  17. qUnitat Docent Vall d’Hebron, Universitat Autònoma de Barcelona, Plaça Cívica, 08193 Bellaterra, Barcelona, Spain
  18. rInfectious Diseases and Immunity, Faculty of Medicine, Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Carrer de la Sagrada Família, 7, 08500 Vic, Spain
  19. sGermans Trias i Pujol Research Institute (IGTP), Carretera de Canyet, s/n, Badalona, Spain
  20. tSpanish Clinical Research Network – SCReN
  21. uCIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid Spain
  22. vCentro de Esclerosis Múltiple de Catalunya (Cemcat), Department of Neurology/Neuroimmunology, Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus, Pg. de la Vall d’Hebron, 119, 08035, Barcelona, Spain
  23. wDepartment of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Plaça Cívica, 08193, Bellaterra, Barcelona, Spain
  24. xClinical Pharmacology Research Group, Vall d’Hebron Institut de Recerca, Pg. de la Vall d’Hebron, 119, 08035, Barcelona, Spain
  1. ↵*Corresponding author: Email address: teresa.prat{at}hipra.com (T Prat)

  1. ↵† Contributed equally and are joint first authors

Back to top
Posted March 02, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, Alexandra Moros, Manuel Cañete, Antonio Barreiro, Luis González-González, Laia Madrenas, Irina Güell, Bonaventura Clotet, Nuria Izquierdo-Useros, Dàlia Raïch-Regué, Marçal Gallemí, Julià Blanco, Edwards Pradenas, Benjamin Trinité, Julia G Prado, Oscar Blanch-Lombarte, Raúl Pérez-Caballero, Montserrat Plana, Ignasi Esteban, Carmen Pastor-Quiñones, Xavier Núñez-Costa, Rachel Abu Taleb, Paula McSkimming, Alex Soriano, Jocelyn Nava, Jesse Omar Anagua, Rafel Ramos, Ruth Martí Lluch, Aida Corpes Comes, Susana Otero Romero, Xavier Martinez Gomez, Carla Sans-Pola, José Moltó, Susana Benet, Lucía Bailón, Jose R Arribas, Alberto M Borobia, Javier Queiruga Parada, Jorge Navarro-Pérez, Maria José Forner Giner, Rafael Ortí Lucas, María del Mar Vázquez Jiménez, Salvador Oña Compán, Melchor Alvarez-Mon, Daniel Troncoso, Eunate Arana-Arri, Susana Meijide, Natale Imaz-Ayo, Patricia Muñoz García, Sofía de la Villa Martínez, Sara Rodríguez Fernández, Teresa Prat, Èlia Torroella, Laura Ferrer
medRxiv 2022.07.05.22277210; doi: https://doi.org/10.1101/2022.07.05.22277210
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area